At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14,151 enrolled
Drug / intervention
candesartan cilexetildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Candesartan Cilexetil Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
In Brief
An observational study evaluating candesartan cilexetil for Hypertension. Completed, enrolled 14,151 participants.
Detailed Summary
The purpose of this survey is designed to investigate the treatment status of hypertensive patient with metabolic syndrome-related risk factors treated with candesartan cilexetil tablets (Blopress Tablets), as well as to assess relationships between risk factors (example, visceral fat accumulation) and the incidence of cerebrovascular/cardiovascular events in an exploratory manner.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2006
Primary CompletionNov 2010
First PostedJun 2014
TodayJul 2026
First PostedJun 18, 2014
Enrollment StartJun 1, 2006
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 12.0 years ago
Interventions
candesartan cilexetildrug
candesartan cilexetil tablets